Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Kazuhiro Yanagihara
Kenichi Yoshimura
Miyuki Niimi
Hiroyasu Yasuda
Takahiko Sasaki
Takafumi Nishimura
Hiroshi Ishiguro
Shigemi Matsumoto
Toshiyuki Kitano
Masashi Kanai
Akiko Misawa
Harue Tada
Satoshi Teramukai
Tadashi Mio
Masanori Fukushima
机构：
[1] Kyoto University Hospital,Outpatient Oncology Unit
[2] Kyoto University,Department of Translational Clinical Oncology, Graduate School of Medicine
[3] Kyoto University Hospital,Department of Clinical Trial Design and Management, Translational Research Center
[4] Kyoto University,Department of Multidisciplinary Cancer Treatment, Graduate School of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Non-small cell lung cancer; Phase II study; Docetaxel; S-1; Second-line chemotherapy; Third-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：913 / 918
页数：5
相关论文
共 50 条
  • [41] A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer
    Hasegawa, Yoshikazu
    Okamoto, Isamu
    Takezawa, Ken
    Miyazaki, Masaaki
    Tsurutani, Junji
    Yonesaka, Kimio
    Morinaga, Ryotaroh
    Tsuya, Asuka
    Terashima, Masaaki
    Kudoh, Toshihiro
    Azuma, Koichi
    Kurata, Takayasu
    Nishikawa, Tatsuyuki
    Fukuoka, Masahiro
    Nishimura, Yasumasa
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 599 - 604
  • [42] PHASE I/II STUDY OF DOCETAXEL AND S-1 IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): THE TOKYO COOPERATIVE ONCOLOGY GROUP
    Shimokawa, T.
    Gemma, A.
    Kudoh, S.
    Takiguchi, Y.
    Tada, Y.
    Yoshimori, K.
    Hino, M.
    Yoshimura, A.
    Nagao, K.
    Niitani, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 107 - 107
  • [43] A phase II study of docetaxel (D) plus imatinib (I) in patients with previously treated non-small cell lung cancer
    White, L. A., Jr.
    Schmidt, A. M.
    Sjak-Shie, N. N.
    Greco, A. O.
    Cronin, B.
    Fisher, K. L.
    Eckardt, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
    Francesca Russo
    Alessandra Bearz
    Gianni Pampaloni
    BMC Cancer, 8
  • [45] Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer
    Yu Nishijima-Futami
    Seigo Minami
    Shinji Futami
    Taro Koba
    Masayoshi Higashiguchi
    Motohiro Tamiya
    Hidekazu Suzuki
    Tomonori Hirashima
    Kiyoshi Komuta
    Takashi Kijima
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1215 - 1220
  • [46] Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients
    Zhang, Guan-Zhong
    Jiao, Shun-Chang
    Meng, Zhao-Ting
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
  • [47] Phase II Study of S-1 plus Bevacizumab Combination Therapy for Patients Previously Treated for Non-Squamous Non-Small Cell Lung Cancer
    Masuhiro, K.
    Nishijima-Futami, Y.
    Minami, S.
    Futami, S.
    Koba, T.
    Higashiguchi, M.
    Tamiya, M.
    Suzuki, H.
    Hirashima, T.
    Komuta, K.
    Kijima, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1968 - S1968
  • [48] Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
    Russo, Francesca
    Bearz, Alessandra
    Pampaloni, Gianni
    ANNALS OF ONCOLOGY, 2007, 18 : 26 - 26
  • [49] Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
    Russo, Francesca
    Bearz, Alessandra
    Pampaloni, Gianni
    BMC CANCER, 2008, 8 (1)
  • [50] Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer
    Nishijima-Futami, Yu
    Minami, Seigo
    Futami, Shinji
    Koba, Taro
    Higashiguchi, Masayoshi
    Tamiya, Motohiro
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Komuta, Kiyoshi
    Kijima, Takashi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1215 - 1220
12345